EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neuronally‐Derived Extracellular Vesicles Transforming Growth Factor Beta‐1 Levels in Progressive Supranuclear Palsy

Selena Mimmi, Elvira Immacolata Parrotta, Anna Maria Tolomeo iD, Domenico Maisano, Valentina Crapella, Elisabetta Pingitore, Khushboo Fatima, Anna Maria Zimbo, Mariagrazia Talarico, Costanza Maria Cristiani, Luana Scaramuzzino, Desirèe Valente und 5 weitere

Movement Disorders · 2025

DOI: 10.1002/mds.30222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Selena Mimmi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Center, Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Extracellular Vesicles, Transforming Growth Factor beta1, Multiple System Atrophy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEXTGENERATIONEU (NGEU), Italian Ministry of University and Research (MUR), National Recovery and Resilience Plan (NRRP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Differentiating progressive supranuclear palsy (PSP) from other parkinsonian disorders may be challenging.

Objectives

To investigate the role of transforming growth factor beta‐1 (TGFβ1) in PSP.

Methods

A total of 33 PSP, 39 Parkinson's disease (PD), 8 multiple system atrophy (MSA) patients, and 50 healthy controls (HC) were enrolled. TGFβ1 levels, including both active and inactive forms (latency‐associated peptide [LAP]‐TGFβ1), were measured in serum, total extracellular vesicles (EVs), and neuronally‐derived EVs (NDEVs) using microfluidic assays and ELISA.

Results

PSP patients exhibited a marked increase in TGFβ1 and LAP‐TGFβ1 levels in NDEVs, while no differences were observed across groups in serum or total EVs. Receiver operating characteristic (ROC) analysis demonstrated outstanding performance in differentiating PSP from non‐PSP patients (TGFβ1, area under the curve [AUC]: 0.97; LAP‐TGFβ1, AUC: 1.00), HC, AUC: 1.00).

Conclusions

This study highlights TGFβ1 and LAP‐TGFβ1 in NDEVs as promising blood‐based non‐invasive biomarkers for PSP diagnosis, paving the way for further research on these proteins in PSP. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Supranuclear Palsy, ProgressiveExtracellular VesiclesTransforming Growth Factor beta1Multiple System AtrophyParkinson DiseaseNeuronsHumansMaleFemaleAgedMiddle AgedBiomarkersROC Curve

Substanzen

Transforming Growth Factor beta1TGFB1 protein, humanBiomarkers

Autor:innen und Institutionen

  • Neuroscience Research Center, Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, Italy.
  • Department of Cardiac, Thoracic and Vascular Science and Public Health, University of Padova, Padua, Italy.
  • Institute of Pediatric Research 'Città della Speranza', Padua, Italy.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Experimental and Clinical Medicine, University Magna Graecia of Catanzaro, Catanzaro, Italy.

ORCID-Profile: Anna Maria Tolomeo, Aldo Quattrone, Enrico Iaccino, Andrea Quattrone

Förderung

  • NEXTGENERATIONEU (NGEU)
  • Italian Ministry of University and Research (MUR)
  • National Recovery and Resilience Plan (NRRP)
  • MNESYS
  • The EFLM Research Grant was provided to E. Iaccino.
  • Ministero dell'Università e della Ricerca

Zitieren

APA

Mimmi, S., Parrotta, E. I., Tolomeo, A. M., Maisano, D., Crapella, V., Pingitore, E., Fatima, K., Zimbo, A. M., Talarico, M., Cristiani, C. M., Scaramuzzino, L., Valente, D., Zannino, C., Cuda, G., Quattrone, A., Iaccino, E., & Quattrone, A. (2025). Neuronally‐Derived Extracellular Vesicles Transforming Growth Factor Beta‐1 Levels in Progressive Supranuclear Palsy. Movement Disorders. https://doi.org/10.1002/mds.30222

Vancouver

Mimmi S, Parrotta EI, Tolomeo AM, Maisano D, Crapella V, Pingitore E, et al. Neuronally‐Derived Extracellular Vesicles Transforming Growth Factor Beta‐1 Levels in Progressive Supranuclear Palsy. Movement Disorders. 2025. doi:10.1002/mds.30222

BibTeX
@article{Mimmi2025,
  author = {Mimmi, Selena and Parrotta, Elvira Immacolata and Tolomeo, Anna Maria and Maisano, Domenico and Crapella, Valentina and Pingitore, Elisabetta and Fatima, Khushboo and Zimbo, Anna Maria and Talarico, Mariagrazia and Cristiani, Costanza Maria and Scaramuzzino, Luana and Valente, Desirèe and Zannino, Clara and Cuda, Gianni and Quattrone, Aldo and Iaccino, Enrico and Quattrone, Andrea},
  title = {Neuronally‐Derived Extracellular Vesicles Transforming Growth Factor Beta‐1 Levels in Progressive Supranuclear Palsy},
  journal = {Movement Disorders},
  year = {2025},
  doi = {10.1002/mds.30222}
}
Kostenlos starten →